OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
Virginia L. Stauffer, Ira Turner, Phebe Kemmer, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Virginia L. Stauffer, Ira Turner, Phebe Kemmer, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Showing 16 citing articles:
Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
Danuta Szkutnik-Fiedler
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1180-1180
Open Access | Times Cited: 86
Danuta Szkutnik-Fiedler
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1180-1180
Open Access | Times Cited: 86
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Francesca Puledda, Simona Sacco, Hans‐Christoph Diener, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 14
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
Lucas Hendrik Overeem, Bianca Raffaelli, Jasper Mecklenburg, et al.
CNS Drugs (2021) Vol. 35, Iss. 8, pp. 805-820
Open Access | Times Cited: 45
Lucas Hendrik Overeem, Bianca Raffaelli, Jasper Mecklenburg, et al.
CNS Drugs (2021) Vol. 35, Iss. 8, pp. 805-820
Open Access | Times Cited: 45
Migraine in older adults
Sarah Sonja Hugger, Thien Phu, Håkan Ashina, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 10, pp. 934-945
Open Access | Times Cited: 13
Sarah Sonja Hugger, Thien Phu, Håkan Ashina, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 10, pp. 934-945
Open Access | Times Cited: 13
Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review
Albert Muñoz‐Vendrell, A. López-Bravo, Almudena Layos-Romero, et al.
Pain Management (2025), pp. 1-11
Closed Access
Albert Muñoz‐Vendrell, A. López-Bravo, Almudena Layos-Romero, et al.
Pain Management (2025), pp. 1-11
Closed Access
Hellenic Headache Society Recommendations for the Use of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide Pathway for the Prevention of Migraine and Cluster Headache—2023 Update
Dimos D. Mitsikostas, A. Alexoudi, Chrysa Arvaniti, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Dimos D. Mitsikostas, A. Alexoudi, Chrysa Arvaniti, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Artificial intelligence analysis to explore synchronize exercise, cobalamin, and magnesium as new actors to therapeutic of migraine symptoms: a randomized, placebo-controlled trial
Hanie Matin, Farzaneh Taghian, Ahmad Chitsaz
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4413-4424
Closed Access | Times Cited: 14
Hanie Matin, Farzaneh Taghian, Ahmad Chitsaz
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4413-4424
Closed Access | Times Cited: 14
Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
Slobodan Јаnkovic, Snežana V. Janković
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 3, pp. 277-293
Closed Access | Times Cited: 2
Slobodan Јаnkovic, Snežana V. Janković
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 3, pp. 277-293
Closed Access | Times Cited: 2
A long-term open-label safety study of galcanezumab in Japanese patients with migraine
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Expert Opinion on Drug Safety (2021), pp. 1-13
Open Access | Times Cited: 15
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Expert Opinion on Drug Safety (2021), pp. 1-13
Open Access | Times Cited: 15
Efficacy and Tolerability of Anti-CGRP Monoclonal Antibodies in Patients Aged ≥ 65 Years With Daily or Nondaily Migraine
Amira Salim, Sudipa Biswas, Claire Sonneborn, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Amira Salim, Sudipa Biswas, Claire Sonneborn, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
Yoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, et al.
Neurology and Therapy (2021) Vol. 10, Iss. 1, pp. 265-278
Open Access | Times Cited: 8
Yoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, et al.
Neurology and Therapy (2021) Vol. 10, Iss. 1, pp. 265-278
Open Access | Times Cited: 8
The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1223-1235
Closed Access | Times Cited: 4
Abimael González‐Hernández, Bruno A. Marichal‐Cancino, Carlos M. Villalón
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1223-1235
Closed Access | Times Cited: 4
(CGRP) Monocloncal antibodies
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
A eficácia do Galcanezumabe na profilaxia de cefaleia crônica migrânea: uma revisão integrativa
Beatriz de Melo Pessôa, Yasmin Nunes Machado, Layane Xavier Sales, et al.
Brazilian Journal of Development (2023) Vol. 9, Iss. 3, pp. 9490-9509
Open Access
Beatriz de Melo Pessôa, Yasmin Nunes Machado, Layane Xavier Sales, et al.
Brazilian Journal of Development (2023) Vol. 9, Iss. 3, pp. 9490-9509
Open Access
Prevention of Migraine
Ashley Holdridge, Jennifer Buczyner, Cristina Cabret Aymat, et al.
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 558-570
Closed Access
Ashley Holdridge, Jennifer Buczyner, Cristina Cabret Aymat, et al.
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 558-570
Closed Access
3º CONGRESSO INTERDISCIPLINAR DA ÁREA MÉDICA
Revista Recima
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2022) Vol. 3, Iss. 1, pp. e3122557-e3122557
Open Access
Revista Recima
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2022) Vol. 3, Iss. 1, pp. e3122557-e3122557
Open Access
